Invivyd, Inc. advances VYD2311 as a Covid-19 vaccine alternative. Learn about upcoming trials and market opportunities. Click ...
Another, the RSV vaccine. A study in The Lancet saw the vaccines were about 80% effective in preventing ICU admission and ...
A new study has identified three existing medications that could be repurposed to treat or prevent Alzheimer's disease.
Among the most commonly cited reasons for COVID vaccine hesitation are fears about side effects, long-term health ...
Last week, Canada officially lost its measles elimination status, which it held for nearly 30 years — a shameful consequence ...
1d
NanoViricides, Inc. Has Filed its Quarterly Report - Subsequent Raise Has Fortified Fiscal Position
NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ending September 30, 2025 with the Securities and Exchange ...
Merck said on Monday it expects a commercial opportunity exceeding $5 billion from Cidara Therapeutics' experimental flu drug ...
Researchers at MIT have just developed a new lipid nanoparticle that super-enhances the effectiveness of the mRNA vaccine in ...
Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, gaining access to an experimental flu drug in its ...
The Healthy @Reader's Digest on MSN
An RSV Vaccine Has Received FDA Approval for Older Adults
The RSV vaccine is specifically created and approved for administration in older adults. Back in March, the FDA recommended ...
Vinay Prasad and Tracy Beth Høeg mix skepticism with new ways to define risk in pursuing sweeping changes to vaccine policy at the FDA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback